ArticleCancer medicine2018

Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.

Ji Yeon Son et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.